Clinical Trial Update: Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations [Phase 2]

View source ↗

Summary

Phase 2 trial assessing fibroblast growth factor–based regeneration for tympanic membrane perforations has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tympanic Membrane Perforation

Drugs mentioned

• Fibroblast Growth Factor (Fibroblast Growth Factor)

Snippet

Sponsor: NYU Langone Health | Conditions: Tympanic Membrane Perforation | Phase 2 | Status: COMPLETED